VA Fibromyalgia Claims: DC 5025 Ratings and the Gulf War Presumptive

What Is Fibromyalgia

Fibromyalgia is a long-term condition characterized by widespread body pain, fatigue, sleep disturbance, and cognitive difficulties. Researchers believe it affects how the brain and spinal cord process pain signals. There is no inflammation or visible structural damage on imaging, which is why the VA describes it as widespread musculoskeletal pain with tender points.

For VA rating purposes, "widespread pain" has a specific definition. It must be present on both the left and right sides of the body, both above and below the waist, and must affect the axial skeleton (cervical spine, anterior chest, thoracic spine, low back) and the extremities. A diagnosis that does not meet that full distribution may not satisfy the DC 5025 criteria.

Associated symptoms listed in the rating criteria include fatigue, sleep disturbance, morning stiffness, headaches, irritable bowel syndrome, depression, anxiety, and Raynaud's-like symptoms. These are listed as "with or without" modifiers, meaning you do not need all of them, but their presence may open secondary-condition claims. See the IBS claims guide for how secondary IBS ratings work.

DC 5025 Rating Criteria: 10, 20, and 40 Percent

Under 38 CFR 4.71a, DC 5025, all three compensable levels require widespread musculoskeletal pain and tender points, with or without the associated symptoms listed above. The rating then turns on how frequent and how treatable the symptoms are.

The Gulf War Presumptive Path: 38 CFR 3.317

For veterans who served in a qualifying location in the Southwest Asia theater, fibromyalgia is a named medically unexplained chronic multisymptom illness (MUCMI) under 38 CFR 3.317. The VA presumes service connection without requiring a nexus letter connecting the diagnosis to service. This is the strongest available path for eligible veterans.

Who qualifies

You must have served in the Southwest Asia theater of operations on or after August 2, 1990, or in other qualifying locations added under the PACT Act. Qualifying locations include the Persian Gulf, Iraq, Kuwait, Saudi Arabia, Bahrain, Qatar, the UAE, Oman, Afghanistan, and others, including the airspace above these areas. Some locations require boots on ground; the airspace provision applies differently depending on the specific region. See the Gulf War illness claims guide and the Gulf War presumptive reference page for the full location list.

Requirements under 3.317

• Qualifying service location: as above.
• Chronicity: the condition must have persisted for six months or more. The VA considers a chronic disability one that has been present at least six months. If you file before reaching that threshold, the claim may not be grantable yet under this theory.
• No identified cause: if your fibromyalgia is clearly caused by an identifiable event unrelated to service (such as a civilian surgery), the MUCMI presumptive is harder to establish. A no-cause or idiopathic characterization in your records supports this theory.
• Diagnosis helpful but not always required: 3.317 technically covers undiagnosed illnesses as well, but for fibromyalgia, having the formal diagnosis is advantageous because the condition is recognized by name as a MUCMI.

Direct and Secondary Paths (Non-Gulf-War Veterans)

Veterans without qualifying Gulf War service have three additional paths, all of which require more evidence than the 3.317 presumptive.

Direct service connection

The standard three-element test applies: current diagnosis, an in-service event or onset, and a medical nexus linking them. If your service records document fibromyalgia symptoms in service, or if you were diagnosed while on active duty, the direct path is viable. A credible nexus opinion from a licensed physician is typically required. The evidence foundation must be clean: the examiner's narrative must align with your service records and not contradict itself (for example, attributing the cause to something outside of service).

Secondary service connection

Fibromyalgia can theoretically be claimed as secondary to a service-connected condition. The M21 manual does not bar it. However, this path requires a nexus opinion from a physician who is willing to state that the service-connected condition caused or aggravated the fibromyalgia, and the evidence supporting that link must be strong. C&P examiners may scrutinize this theory closely. A "primary fibromyalgia syndrome" entry in your medical records (meaning no identifiable cause) works against a secondary theory.

The more useful direction is the reverse: using service-connected fibromyalgia as an anchor condition to claim secondaries from it. Conditions commonly associated with fibromyalgia include:

• Depression and anxiety: must be documented as separate diagnoses, not just symptoms absorbed into the fibromyalgia rating. Chronic pain causing depression is a well-supported secondary theory.
• Irritable bowel syndrome: recognized as associated with fibromyalgia. Examiners may require stronger evidence for this link. See the IBS claims guide.
• Headaches: can be secondary to fibromyalgia, but a separate diagnosis (not just a symptom of fibromyalgia itself) is needed for a separately compensable rating above 0%.

TERA (toxic exposure) path

The PACT Act introduced the Toxic Exposure Risk Activity framework under 38 CFR 3.317 and related regulations. If you did not serve in a qualifying Gulf War location but were exposed to specific chemicals or toxic agents during service, a claim that those exposures caused fibromyalgia is legally possible. This theory depends on the specific chemicals involved and whether a medical examiner can establish a link between that exposure and fibromyalgia. Evidence demands are high. See toxic exposure appeals data.

Chronic disability presumptive (38 CFR 3.309(a))

If you were diagnosed with fibromyalgia within one year of separation from active duty, the condition may be presumptively service-connected as a chronic disability under 38 CFR 3.309(a) without requiring in-service documentation of symptoms. The diagnosis must fall within that one-year window.

Evidence That Wins These Claims

• Current diagnosis from a licensed provider. The diagnosis must meet the clinical criteria for fibromyalgia. Examiners often reference Mayo Clinic criteria. Make sure your records use the term "fibromyalgia" explicitly and document the widespread pain distribution and tender points.
• Documentation of widespread pain distribution. The VA's definition requires both sides, above and below the waist, and axial skeleton involvement. Records that document the full distribution support the DC 5025 criteria.
• Symptom diary or tracking log. For 20% vs. 40%, the frequency and pattern of symptoms is decisive. A dated record of symptom severity, how often you have flares, whether rest helps, and what treatments you have tried makes the exacerbation and refractory-to-therapy criteria concrete rather than relying on memory during a C&P exam.
• Treatment records showing continuous medication. The 10% level requires continuous medication for control. Records documenting what medications you take and why establish this.
• Documentation of treatment failure (for 40%). The refractory-to-therapy standard means you have tried treatments and they have not adequately controlled the condition. Records showing trials of different medications, physical therapy, or other interventions that provided insufficient relief support a 40% rating.
• The fibromyalgia DBQ. Get a copy of the completed DBQ after any C&P exam. Verify that question 2B (continuous medication), 2D (refractory to therapy), and 3B (symptom frequency pattern) are answered accurately and consistently with your records. See the DBQ guide.
• Nexus letter (for direct or secondary paths). A letter from a physician who reviews your service records and treatment history, and who can provide a reasoned medical opinion that your fibromyalgia is related to service or to a service-connected condition. See nexus letters.
• Lay statements on continuity of symptoms. Your own statement, or statements from people who know you, about how your symptoms have persisted since service and how they affect daily functioning. See buddy statements.
• NPI number verification for private DBQs. If you obtain a private DBQ, the examiner's National Provider Index number, address, phone, and fax must match what is on the NPI registry. Discrepancies give the VA grounds to question the document's authenticity.

Anti-Pyramiding: Fibromyalgia and Other Joint or Pain Conditions

Under 38 CFR 4.14, the same symptom cannot be used to support ratings under two different diagnostic codes. Because fibromyalgia produces widespread musculoskeletal pain, it can overlap symptomatically with separately rated joint conditions (such as a service-connected knee, shoulder, or back condition).

The rule operates symptom by symptom, not condition by condition. You can be rated for both fibromyalgia and a separately rated joint condition as long as the symptoms being rated are distinct. What you cannot do is use, for example, knee pain that is already being compensated under a knee rating as a basis for rating fibromyalgia pain in the same joint.

In practice, if evidence is ambiguous about which condition is causing a particular symptom, the VA rater is supposed to resolve the ambiguity in the veteran's favor by applying the most advantageous interpretation. But it is better to have records that distinguish fibromyalgia's widespread systemic pain from the localized symptoms of separately rated conditions.

Frequently Asked Questions